{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T07:38:29Z","timestamp":1792222709510,"version":"4.4.0"},"reference-count":61,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,11,11]],"date-time":"2021-11-11T00:00:00Z","timestamp":1636588800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000902","name":"Pediatric Cancer Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000902","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Robust T cell responses are crucial for effective anti-tumor responses and often dictate patient survival. However, in the context of solid tumors, both endogenous T cell responses and current adoptive T cell therapies are impeded by the immunosuppressive tumor microenvironment (TME). A multitude of inhibitory signals, suppressive immune cells, metabolites, hypoxic conditions and limiting nutrients are believed to render the TME non-conducive to sustaining productive T cell responses. In this study we conducted an in-depth phenotypic and functional comparison of tumor-specific T cells and tumor-nonspecific bystander memory T cells within the same TME. Using two distinct TCR transgenic and solid-tumor models, our data demonstrate that despite exposure to the same cell-extrinsic factors of the TME, the tumor-nonspecific bystander CD8 T cells retain the complete panoply of memory markers, and do not share the same exhaustive phenotype as tumor-reactive T cells. Compared to tumor-specific T cells, bystander memory CD8 T cells in the TME also retain functional effector cytokine production capabilities in response to <jats:italic>ex vivo<\/jats:italic> cognate antigenic stimulation. Consistent with these results, bystander memory T cells isolated from tumors showed enhanced recall responses to secondary bacterial challenge in a T cell transplant model. Importantly, the tumor-resident bystander memory cells could also efficiently utilize the available resources within the TME to elaborate <jats:italic>in situ<\/jats:italic> recall effector functions following intra-tumoral peptide antigen injection. Additionally, CRISPR-Cas9 gene deletion studies showed that CXCR3 was critical for the trafficking of both tumor antigen-specific and bystander memory T cells to solid tumors. Collectively, these findings that T cells can persist and retain their functionality in distinct solid tumor environments in the absence of cognate antigenic stimulation, support the notion that persistent antigenic signaling is the central driver of T cell exhaustion within the TME. These studies bear implications for programming more efficacious TCR- and CAR-T cells with augmented therapeutic efficacy and longevity through regulation of antigen and chemokine receptors.<\/jats:p>","DOI":"10.3389\/fimmu.2021.706150","type":"journal-article","created":{"date-parts":[[2021,11,11]],"date-time":"2021-11-11T15:26:52Z","timestamp":1636644412000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Solid Tumor Microenvironment Can Harbor and Support Functional Properties of Memory T Cells"],"prefix":"10.3389","volume":"12","author":[{"given":"Peter M.","family":"Sullivan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven James","family":"Reed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vandana","family":"Kalia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surojit","family":"Sarkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,11,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"xii18","DOI":"10.1093\/annonc\/mdx238","article-title":"Mechanisms Regulating T-Cell Infiltration and Activity in Solid Tumors","volume":"28","author":"Lanitis","year":"2017","journal-title":"Ann Oncol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1200\/EDBK_180328","article-title":"Adoptive T-Cell Therapy for Solid Tumors","volume":"37","author":"Yeku","year":"2017","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-13-0985","article-title":"T-Cell and NK-Cell Infiltration Into Solid Tumors: A Key Limiting Factor for Efficacious Cancer Immunotherapy","volume":"4","author":"Melero","year":"2014","journal-title":"Cancer Discovery"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2035","article-title":"T Cell Exhaustion","volume":"12","author":"Wherry","year":"2011","journal-title":"Nat Immunol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1126\/science.aaa6204","article-title":"T Cell Exclusion, Immune Privilege, and the Tumor Microenvironment","volume":"348","author":"Joyce","year":"2015","journal-title":"Science"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01591","article-title":"Hypoxia-Driven Immunosuppressive Metabolites in the Tumor Microenvironment: New Approaches for Combinational Immunotherapy","volume":"9","author":"Li","year":"2018","journal-title":"Front Immunol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-041015-055318","article-title":"CD8 T Cell Exhaustion During Chronic Viral Infection and Cancer","volume":"37","author":"McLane","year":"2019","journal-title":"Annu Rev Immunol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1200\/JCO.2014.59.4358","article-title":"Immune Checkpoint Blockade in Cancer Therapy","volume":"33","author":"Postow","year":"2015","journal-title":"J Clin Oncol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1126\/science.aar4060","article-title":"Cancer Immunotherapy Using Checkpoint Blockade","volume":"359","author":"Ribas","year":"2018","journal-title":"Science"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-med-012017-043208","article-title":"CD8 T Cell Exhaustion in Chronic Infection and Cancer: Opportunities for Interventions","volume":"69","author":"Hashimoto","year":"2018","journal-title":"Annu Rev Med"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2007.09.006","article-title":"Molecular Signature of CD8+ T Cell Exhaustion During Chronic Viral Infection","volume":"27","author":"Wherry","year":"2007","journal-title":"Immunity"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00340","article-title":"Enhanced Phenotype Definition for Precision Isolation of Precursor Exhausted Tumor-Infiltrating CD8 T Cells","volume":"11","author":"Martinez-Usatorre","year":"2020","journal-title":"Front Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-019-0312-6","article-title":"Subsets of Exhausted CD8+ T Cells Differentially Mediate Tumor Control and Respond to Checkpoint Blockade","volume":"20","author":"Miller","year":"2019","journal-title":"Nat Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/nature19330","article-title":"Defining CD8+ T Cells That Provide the Proliferative Burst After PD-1 Therapy","volume":"537","author":"Im","year":"2016","journal-title":"Nature"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/nature19317","article-title":"Follicular CXCR5-Expressing CD8+ T Cells Curtail Chronic Viral Infection","volume":"537","author":"He","year":"2016","journal-title":"Nature"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/j.immuni.2019.11.002","article-title":"Proliferating Transitory T Cells With an Effector-Like Transcriptional Signature Emerge From PD-1+ Stem-Like CD8+ T Cells During Chronic Infection","volume":"51","author":"Hudson","year":"2019","journal-title":"Immunity"},{"key":"B17","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.immuni.2018.12.021","article-title":"Intratumoral Tcf1+ PD-1+ CD8+ T Cells With Stem-Like Properties Promote Tumor Control in Response to Vaccination and Checkpoint Blockade Immunotherapy","volume":"50","author":"Siddiqui","year":"2019","journal-title":"Immunity"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1601064","article-title":"Virus-Specific CD8+ T Cells Infiltrate Melanoma Lesions and Retain Function Independently of PD-1 Expression","volume":"198","author":"Erkes","year":"2017","journal-title":"J Immunol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-019-08534-1","article-title":"Virus-Specific Memory T Cells Populate Tumors and Can Be Repurposed for Tumor Immunotherapy","volume":"10","author":"Rosato","year":"2019","journal-title":"Nat Commun"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-018-0130-2","article-title":"Bystander CD8+ T Cells are Abundant and Phenotypically Distinct in Human Tumour Infiltrates","volume":"557","author":"Simoni","year":"2018","journal-title":"Nature"},{"key":"B21","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.immuni.2016.07.011","article-title":"Tumor-Specific T Cell Dysfunction Is a Dynamic Antigen-Driven Differentiation Program Initiated Early During Tumorigenesis","volume":"45","author":"Schietinger","year":"2016","journal-title":"Immunity"},{"key":"B22","doi-asserted-by":"publisher","first-page":"e102709","DOI":"10.1371\/journal.pone.0102709","article-title":"Bystander Activation and Anti-Tumor Effects of CD8+ T Cells Following Interleukin-2 Based Immunotherapy is Independent of CD4+ T Cell Help","volume":"9","author":"Monjazeb","year":"2014","journal-title":"PloS One"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-018-05072-0","article-title":"Co-Expression of CD39 and CD103 Identifies Tumor-Reactive CD8 T Cells in Human Solid Tumors","volume":"9","author":"Duhen","year":"2018","journal-title":"Nat Commun"},{"key":"B24","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/s41591-018-0266-5","article-title":"Low and Variable Tumor Reactivity of the Intratumoral TCR Repertoire in Human Cancers","volume":"25","author":"Scheper","year":"2019","journal-title":"Nat Med"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ncomms8458","article-title":"Non-Redundant Requirement for CXCR3 Signalling During Tumoricidal T-Cell Trafficking Across Tumour Vascular Checkpoints","volume":"6","author":"Mikucki","year":"2015","journal-title":"Nat Commun"},{"key":"B26","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.4049\/jimmunol.1502376","article-title":"Chemoattractant Receptors BLT1 and CXCR3 Regulate Antitumor Immunity by Facilitating CD8+ T Cell Migration Into Tumors","volume":"197","author":"Chheda","year":"2016","journal-title":"J Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-10-0712","article-title":"Transduction of Tumor-Specific T Cells With CXCR2 Chemokine Receptor Improves Migration to Tumor and Antitumor Immune Responses","volume":"16","author":"Peng","year":"2010","journal-title":"Clin Cancer Res"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2018-316595","article-title":"Switchable CAR-T Cells Mediate Remission in Metastatic Pancreatic Ductal Adenocarcinoma","volume":"68","author":"Raj","year":"2019","journal-title":"Gut"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1101\/2020.01.26.920496","article-title":"Transient \u201cRest\u201d Induces Functional Reinvigoration and Epigenetic Remodeling in Exhausted CAR-T Cells","author":"Weber","year":"2020","journal-title":"bioRxiv"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1911154117","article-title":"A Conformation-Specific ON-Switch for Controlling CAR T Cells With an Orally Available Drug","volume":"117","author":"Zajc","year":"2020","journal-title":"Proc Natl Acad Sci"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-020-20671-6","article-title":"Direct Control of CAR T Cells Through Small Molecule-Regulated Antibodies","volume":"12","author":"Park","year":"2021","journal-title":"Nat Commun"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2019.00233","article-title":"Doxycycline Inducible Chimeric Antigen Receptor T Cells Targeting CD147 for Hepatocellular Carcinoma Therapy","volume":"7","author":"Zhang","year":"2019","journal-title":"Front Cell Dev Biol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12896-019-0537-3","article-title":"Modulation of Chimeric Antigen Receptor Surface Expression by a Small Molecule Switch","volume":"19","author":"Juillerat","year":"2019","journal-title":"BMC Biotechnol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2020.06.004","article-title":"Ligand-Induced Degradation of a CAR Permits Reversible Remote Control of CAR T Cell Activity In Vitro and In Vivo","volume":"28","author":"Richman","year":"2020","journal-title":"Mol Ther"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-06-435412","article-title":"MicroRNA-17\u223c 92 Regulates Effector and Memory CD8 T-Cell Fates by Modulating Proliferation in Response to Infections","volume":"121","author":"Khan","year":"2013","journal-title":"Blood"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2015.05.023","article-title":"Quiescence of Memory CD8+ T Cells Is Mediated by Regulatory T Cells Through Inhibitory Receptor CTLA-4","volume":"42","author":"Kalia","year":"2015","journal-title":"Immunity"},{"key":"B37","doi-asserted-by":"publisher","first-page":"e0162674","DOI":"10.1371\/journal.pone.0162674","article-title":"Dicer Regulates the Balance of Short-Lived Effector and Long-Lived Memory CD8 T Cell Lineages","volume":"11","author":"Baumann","year":"2016","journal-title":"PloS One"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/cmi.2014.48","article-title":"Early CD8 T-Cell Memory Precursors and Terminal Effectors Exhibit Equipotent In Vivo Degranulation","volume":"12","author":"Yuzefpolskiy","year":"2015","journal-title":"Cell Mol Immunol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1800906","article-title":"Programming of CD8 T Cell Quantity and Polyfunctionality by Direct IL-1 Signals","volume":"201","author":"Sarkar","year":"2018","journal-title":"J Immunol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41423-019-0306-1","article-title":"Myeloid Immunosuppression and Immune Checkpoints in the Tumor Microenvironment","volume":"17","author":"Nakamura","year":"2020","journal-title":"Cell Mol Immunol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.csbj.2018.11.004","article-title":"Fates of CD8+ T Cells in Tumor Microenvironment","volume":"17","author":"Maimela","year":"2019","journal-title":"Comput Struct Biotechnol J"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.00017","article-title":"T Cell Dysfunction and Exhaustion in Cancer","volume":"8","author":"Zhang","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2018.03.012","article-title":"T Cell Dysfunction in Cancer","volume":"33","author":"Thommen","year":"2018","journal-title":"Cancer Cell"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1718217115","article-title":"Role of PD-1 During Effector CD8 T Cell Differentiation","volume":"115","author":"Ahn","year":"2018","journal-title":"Proc Natl Acad Sci"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1016\/j.immuni.2019.04.010","article-title":"Intratumoral Activity of the CXCR3 Chemokine System Is Required for the Efficacy of Anti-PD-1 Therapy","volume":"50","author":"Chow","year":"2019","journal-title":"Immunity"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-019-12980-2","article-title":"CXCR3 Enables Recruitment and Site-Specific Bystander Activation of Memory CD8+ T Cells","volume":"10","author":"Maurice","year":"2019","journal-title":"Nat Commun"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2010.12.017","article-title":"CXCR3 in T Cell Function","volume":"317","author":"Groom","year":"2011","journal-title":"Exp Cell Res"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1101881108","article-title":"Expression of Chemokine Receptor CXCR3 on T Cells Affects the Balance Between Effector and Memory CD8 T-Cell Generation","volume":"108","author":"Hu","year":"2011","journal-title":"Proc Natl Acad Sci"},{"key":"B49","doi-asserted-by":"publisher","first-page":"e52330","DOI":"10.7554\/eLife.52330","article-title":"Tumors Attenuating the Mitochondrial Activity in T Cells Escape From PD-1 Blockade Therapy","volume":"9","author":"Kumar","year":"2020","journal-title":"ELife"},{"key":"B50","doi-asserted-by":"publisher","first-page":"e0206223","DOI":"10.1371\/journal.pone.0206223","article-title":"Tumor-Immune Profiling of Murine Syngeneic Tumor Models as a Framework to Guide Mechanistic Studies and Predict Therapy Response in Distinct Tumor Microenvironments","volume":"13","author":"Yu","year":"2018","journal-title":"PloS One"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12864-019-6344-3","article-title":"Comparison of the Molecular and Cellular Phenotypes of Common Mouse Syngeneic Models With Human Tumors","volume":"21","author":"Zhong","year":"2020","journal-title":"BMC Genomics"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1402711","article-title":"CD8+ CD103+ Tumor\u2013Infiltrating Lymphocytes are Tumor-Specific Tissue-Resident Memory T Cells and a Prognostic Factor for Survival in Lung Cancer Patients","volume":"194","author":"Djenidi","year":"2015","journal-title":"J Immunol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1901172","article-title":"Cutting Edge: Antitumor Immunity by Pathogen-Specific CD8 T Cells in the Absence of Cognate Antigen Recognition","volume":"204","author":"Danahy","year":"2020","journal-title":"J Immunol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-14-2458","article-title":"Trafficking of T Cells Into Tumors","volume":"74","author":"Slaney","year":"2014","journal-title":"Cancer Res"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00976","article-title":"CXCR3 Ligands in Cancer and Autoimmunity, Chemoattraction of Effector T Cells, and Beyond","volume":"11","author":"Karin","year":"2020","journal-title":"Front Immunol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-009-0019-1","article-title":"The Chemokine Receptors CXCR4 and CXCR3 in Cancer","volume":"11","author":"Fulton","year":"2009","journal-title":"Curr Oncol Rep"},{"key":"B57","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.ccell.2017.04.003","article-title":"Tumor-Residing Batf3 Dendritic Cells Are Required for Effector T Cell Trafficking and Adoptive T Cell Therapy","volume":"31","author":"Spranger","year":"2017","journal-title":"Cancer Cell"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-020-15404-8","article-title":"Tgf\u03b2 Suppresses CD8+ T Cell Expression of CXCR3 and Tumor Trafficking","volume":"11","author":"Gunderson","year":"2020","journal-title":"Nat Commun"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1038\/nature22367","article-title":"Chromatin States Define Tumour-Specific T Cell Dysfunction and Reprogramming","volume":"545","author":"Philip","year":"2017","journal-title":"Nature"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aau5907","article-title":"The Tyrosine Kinase Inhibitor Dasatinib Acts as a Pharmacologic on\/Off Switch for CAR T Cells","volume":"11","author":"Mestermann","year":"2019","journal-title":"Sci Trans Med"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1126\/science.aba1786","article-title":"Transient Rest Restores Functionality in Exhausted CAR-T Cells Through Epigenetic Remodeling","volume":"372","author":"Weber","year":"2021","journal-title":"Science"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.706150\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,11]],"date-time":"2021-11-11T15:26:56Z","timestamp":1636644416000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.706150\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,11]]},"references-count":61,"alternative-id":["10.3389\/fimmu.2021.706150"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.706150","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,11]]},"article-number":"706150"}}